<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01279434</url>
  </required_header>
  <id_info>
    <org_study_id>ILBS/DHPT/CT/006</org_study_id>
    <nct_id>NCT01279434</nct_id>
  </id_info>
  <brief_title>Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial</brief_title>
  <official_title>Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Liver and Biliary Sciences, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Liver and Biliary Sciences, India</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nonalcoholic fatty liver disease (NAFLD) is a spectrum of hepatic pathology, ranging from
      simple steatosis, steatohepatitis, to cirrhosis. Nonalcoholic steatohepatitis (NASH) is a
      more advanced form of disease where steatosis is accompanied by hepatocyte injury as well as
      infiltration of inflammatory cells. Since, both vitamin E and PTX has been found to improve
      NASH when used alone, a combination of these two should be expected to give better results
      because of targeting two different pathogenetic mechanisms (cytokines amplification and
      oxidative stress) in NASH patients. This will be open labelled, prospective, randomized
      study. The diagnosis of NAFLD will be made on the basis of Ultrasonographic findings
      suggestive of fatty liver and presence of insulin resistance or features of metabolic
      syndrome. Subsequently histologic confirmation of the diagnosis of NASH will be made in all
      cases.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in hepatocyte injury and fibrosis (NAFLD Activity Score [NAS score])</measure>
    <time_frame>Baseline and 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Normalization of serum transaminases levels</measure>
    <time_frame>Baseline and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in serum levels of proinflammatory cytokines (TNF-Î± and IL-6) and Malondialdehyde (MDA).</measure>
    <time_frame>Baseline and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in HOMA-IR</measure>
    <time_frame>Baseline and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No worsening of fibrosis</measure>
    <time_frame>Baseline and 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Non Alcoholic Steatohepatitis</condition>
  <arm_group>
    <arm_group_label>Vitamin E plus Pentoxiphyllin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E plus Pentoxiphyllin</intervention_name>
    <description>Both drugs will be administered daily Vit E (400 mg BD) and pentoxiphyllin (400 mg TDS) for 12 months</description>
    <arm_group_label>Vitamin E plus Pentoxiphyllin</arm_group_label>
    <other_name>Arm A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>Vitamin E 400 mg BD daily for 12 months</description>
    <arm_group_label>Vitamin E</arm_group_label>
    <other_name>Arm B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of NAFLD by ultrasonographic

          -  Presence of Insulin resistance

          -  Histological confirmation of NASH

          -  Increased transaminases (&gt;1.5 upper limit normal [ULN])

        Exclusion Criteria:

          -  Patients with alcohol &gt; 20g/ day

          -  Other known liver disease

          -  Medications known to induce fatty liver
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr Ramesh Kumar, MD,DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Liver and Biliary Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Liver &amp; Biliary Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110070</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2010</study_first_submitted>
  <study_first_submitted_qc>January 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2011</study_first_posted>
  <last_update_submitted>May 27, 2015</last_update_submitted>
  <last_update_submitted_qc>May 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

